TECVAYLI 90 mg/mL
teclistamab-cqyv · INJECTION · Janssen Biotech, Inc.
No Recall History
Plain English
TECVAYLI is a injection containing teclistamab-cqyv at 90 mg/mL, taken subcutaneous. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- TECVAYLI
- Generic Name
- teclistamab-cqyv
- NDC Code (Product)
57894-450- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 90 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761291
- Marketing Start
- 10/25/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is TECVAYLI used for?
TECVAYLI contains teclistamab-cqyv. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is TECVAYLI a controlled substance?
TECVAYLI is not classified as a controlled substance by the DEA.
What is the generic name for TECVAYLI?
The generic name for TECVAYLI is teclistamab-cqyv. There are no other listed brand versions of teclistamab-cqyv.
What is the NDC code for TECVAYLI 90 mg/mL?
The NDC (National Drug Code) for TECVAYLI 90 mg/mL is 57894-450, listed by Janssen Biotech, Inc..
Other TECVAYLI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)